Zevra Therapeutics Gross Margin Growth & History (ZVRA)
Zevra Therapeutics's gross margin was 84.52% for fiscal 2025.
View full Zevra Therapeutics company overviewZevra Therapeutics annual gross margin history
2019
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 84.52% | +15.93 pp |
| 2024 | 2024-12-31 | 68.59% | −20.69 pp |
| 2023 | 2023-12-31 | 89.28% | −8.54 pp |
| 2022 | 2022-12-31 | 97.82% | +5.00 pp |
| 2021 | 2021-12-31 | 92.81% | — |
| 2019 | 2019-12-31 | 22.11% | — |
Zevra Therapeutics quarterly gross margin
Q3.19
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 96.16% | +43.99 pp |
| Q1 2026 | 2026-03-31 | 94.76% | +1.36 pp |
| Q4 2025 | 2025-12-31 | 95.55% | +6.89 pp |
| Q3 2025 | 2025-09-30 | 95.25% | +57.58 pp |
| Q2 2025 | 2025-06-30 | 52.17% | +32.48 pp |
| Q1 2025 | 2025-03-31 | 93.41% | −1.48 pp |
| Q4 2024 | 2024-12-31 | 88.66% | +4.13 pp |
| Q3 2024 | 2024-09-30 | 37.67% | −57.35 pp |
| Q2 2024 | 2024-06-30 | 19.69% | −72.32 pp |
| Q1 2024 | 2024-03-31 | 94.89% | −1.17 pp |
| Q4 2023 | 2023-12-31 | 84.53% | −14.38 pp |
| Q3 2023 | 2023-09-30 | 95.03% | −0.07 pp |
| Q2 2023 | 2023-06-30 | 92.01% | −4.07 pp |
| Q1 2023 | 2023-03-31 | 96.06% | −3.73 pp |
| Q4 2022 | 2022-12-31 | 98.91% | — |
| Q3 2022 | 2022-09-30 | 95.09% | −4.91 pp |
| Q2 2022 | 2022-06-30 | 96.08% | +4.42 pp |
| Q1 2022 | 2022-03-31 | 99.80% | — |
| Q3 2021 | 2021-09-30 | 100.00% | — |
| Q2 2021 | 2021-06-30 | 91.66% | — |
| Q3 2019 | 2019-09-30 | 91.28% | — |
Zevra Therapeutics gross margin trends
Between the periods ended 2019-12-31 and 2025-12-31, Zevra Therapeutics's gross margin increased from 22.11% to 84.52%, a change of +62.41 percentage points. The latest reported quarter, Q2 2026, shows 96.16%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zevra Therapeutics source filings ↗